On April 29th, 2014, the Chemistry laboratories at WMH and BGH will be transitioning to new equipment, the Roche Cobas 6000. For the Chemistry department at WMH, this will represent a platform change for analysis of the tumor markers PSA, CA-125, and CEA. Due to the prognostic nature and utilization of these tests, the laboratory recognizes that in some instances, re-baselining may be of clinical benefit to the patient. As a result, the laboratory will continue to keep the previous instrument, the Siemens Immulite 2000, for a period of time to honor re-baselining requests. For PSA, this will be one (1) month, and for CA-125 and CEA, this will be three (3) months. During this period of time, providers may request that a test be re-baselined by indicating the request on a patientís order.
Should there be any questions, please contact the WMH Chemistry Supervisor, Angela K. Armato, at 763-5780. Thank you.